Systolic blood pressure as a predictor of transient ischemic attack/minor stroke in emergency department patients under age 80: a prospective cohort study.


Journal

BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555

Informations de publication

Date de publication:
25 Oct 2019
Historique:
received: 22 03 2019
accepted: 16 09 2019
entrez: 27 10 2019
pubmed: 28 10 2019
medline: 7 1 2020
Statut: epublish

Résumé

Elevated blood pressure (BP) at emergency department (ED) presentation and advancing age have been associated with risk of ischemic stroke; however, the relationship between BP, age, and transient ischemic attack/minor stroke (TIA/MS) is not clear. A multi-site, prospective, observational study of 1084 ED patients screened for suspected TIA/MS (symptom onset < 24 h, NIHSS< 4) between December 2013 and April 2016. Systolic and diastolic BP measurements (SBP, DBP) were taken at ED presentation. Final diagnosis was consensus adjudication by stroke neurologists; patients were diagnosed as either TIA/MS or stroke-mimic (non-cerebrovascular conditions). Conditional inference trees were used to define age cut-points for predicting binary diagnosis (TIA/MS or stroke-mimic). Logistic regression models were used to estimate the effect of BP, age, sex, and the age-BP interaction on predicting TIA/MS diagnosis. Over a 28-month period, 768 (71%) patients were diagnosed with TIA/MS: these patients were older (mean 71.6 years) and more likely to be male (58%) than stroke-mimics (61.4 years, 41%; each p < 0.001). TIA/MS patients had higher SBP than stroke-mimics (p < 0.001). DBP did not differ between the two groups (p = 0.191). SBP was predictive of TIA/MS diagnosis in younger patients, after accounting for age and sex; an increase of 10 mmHg systolic increased the odds of TIA/MS 18% (odds ratio [OR] 1.18, 95% CI 1.00-1.39) in patients < 60 years, and 23% (OR 1.23, 95% CI 11.12-1.35) in those 60-79 years, while not affecting the odds of TIA/MS in patients ≥80 years (OR 0.99, 95% CI 0.89-1.07). Raised SBP in patients younger than 80 with suspected TIA/MS may be a useful clinical indicator upon initial presentation to help increase clinicians' suspicion of TIA/MS. ClinicalTrials.gov NCT03050099 (10-Feb-2017) and NCT03070067 (3-Mar-2017). Retrospectively registered.

Sections du résumé

BACKGROUND BACKGROUND
Elevated blood pressure (BP) at emergency department (ED) presentation and advancing age have been associated with risk of ischemic stroke; however, the relationship between BP, age, and transient ischemic attack/minor stroke (TIA/MS) is not clear.
METHODS METHODS
A multi-site, prospective, observational study of 1084 ED patients screened for suspected TIA/MS (symptom onset < 24 h, NIHSS< 4) between December 2013 and April 2016. Systolic and diastolic BP measurements (SBP, DBP) were taken at ED presentation. Final diagnosis was consensus adjudication by stroke neurologists; patients were diagnosed as either TIA/MS or stroke-mimic (non-cerebrovascular conditions). Conditional inference trees were used to define age cut-points for predicting binary diagnosis (TIA/MS or stroke-mimic). Logistic regression models were used to estimate the effect of BP, age, sex, and the age-BP interaction on predicting TIA/MS diagnosis.
RESULTS RESULTS
Over a 28-month period, 768 (71%) patients were diagnosed with TIA/MS: these patients were older (mean 71.6 years) and more likely to be male (58%) than stroke-mimics (61.4 years, 41%; each p < 0.001). TIA/MS patients had higher SBP than stroke-mimics (p < 0.001). DBP did not differ between the two groups (p = 0.191). SBP was predictive of TIA/MS diagnosis in younger patients, after accounting for age and sex; an increase of 10 mmHg systolic increased the odds of TIA/MS 18% (odds ratio [OR] 1.18, 95% CI 1.00-1.39) in patients < 60 years, and 23% (OR 1.23, 95% CI 11.12-1.35) in those 60-79 years, while not affecting the odds of TIA/MS in patients ≥80 years (OR 0.99, 95% CI 0.89-1.07).
CONCLUSIONS CONCLUSIONS
Raised SBP in patients younger than 80 with suspected TIA/MS may be a useful clinical indicator upon initial presentation to help increase clinicians' suspicion of TIA/MS.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT03050099 (10-Feb-2017) and NCT03070067 (3-Mar-2017). Retrospectively registered.

Identifiants

pubmed: 31653207
doi: 10.1186/s12883-019-1466-4
pii: 10.1186/s12883-019-1466-4
pmc: PMC6815025
doi:

Banques de données

ClinicalTrials.gov
['NCT03050099', 'NCT03070067']

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

251

Subventions

Organisme : Genome Canada
ID : TIA 4125 - Penn
Organisme : Genome British Columbia
ID : TIA 4125 - Penn
Organisme : Genome Alberta
ID : TIA 4125 - Penn

Références

Neurology. 2017 Apr 11;88(15):1468-1477
pubmed: 28356464
Stroke. 2006 Mar;37(3):769-75
pubmed: 16484610
Stroke. 2010 Apr;41(4):661-6
pubmed: 20185781
Stroke. 2012 Apr;43(4):1013-7
pubmed: 22302109
Lancet. 2007 Jan 27;369(9558):283-92
pubmed: 17258668
Stroke. 2009 Jun;40(6):2276-93
pubmed: 19423857
N Engl J Med. 2002 Nov 21;347(21):1713-6
pubmed: 12444191
Arch Intern Med. 2007 Dec 10;167(22):2417-22
pubmed: 18071162
Neurology. 2009 Jun 2;72(22):1941-7
pubmed: 19487652
JAMA. 2000 Dec 13;284(22):2901-6
pubmed: 11147987
Biometrics. 1949 Jun;5(2):99-114
pubmed: 18151955
Stroke. 1986 Sep-Oct;17(5):861-4
pubmed: 3764955
Stroke. 1984 Jul-Aug;15(4):723-5
pubmed: 6464066
JAMA. 2003 Jul 9;290(2):199-206
pubmed: 12851274
Stroke. 2014 Jul;45(7):2160-236
pubmed: 24788967
Emerg Med J. 2007 Feb;24(2):92-5
pubmed: 17251611
Stroke. 2003 Dec;34(12):2995-8
pubmed: 14605325
Lancet. 2005 Jul 2-8;366(9479):29-36
pubmed: 15993230
Stroke. 1986 Jul-Aug;17(4):723-8
pubmed: 3738956
Stroke. 2014 Jan;45(1):92-100
pubmed: 24262323
Biometrika. 1947;34(1-2):28-35
pubmed: 20287819
Stroke. 2008 Sep;39(9):2461-6
pubmed: 18617658
J Intern Med. 2009 Mar;265(3):388-96
pubmed: 19019190
Neurology. 2004 Jun 8;62(11):2015-20
pubmed: 15184607
JAMA. 2005 Jul 27;294(4):466-72
pubmed: 16046653
J Am Coll Cardiol. 2012 Aug 14;60(7):599-606
pubmed: 22796254
CMAJ. 2004 Mar 30;170(7):1099-104
pubmed: 15051693
Neurology. 2016 Jun 7;86(23):2146-53
pubmed: 27194383
N Engl J Med. 2016 Apr 21;374(16):1533-42
pubmed: 27096581
J Hypertens. 2006 Sep;24(9):1849-56
pubmed: 16915035
Nat Clin Pract Cardiovasc Med. 2006 Oct;3(10):521
pubmed: 16990832
BMJ. 1998 Jun 13;316(7147):1780-4
pubmed: 9624064
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
J Gerontol A Biol Sci Med Sci. 2003 Jul;58(7):653-8
pubmed: 12865483
Cerebrovasc Dis. 2011;32(1):57-64
pubmed: 21613786
J Clin Hypertens (Greenwich). 2014 Apr;16(4):270-6
pubmed: 24621268
Stroke. 2009 Nov;40(11):3449-54
pubmed: 19745173
Ann Emerg Med. 2009 May;53(5):662-73
pubmed: 18849093
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
J Hypertens. 2003 Dec;21(12):2409-17
pubmed: 14654762

Auteurs

Andrew M Penn (AM)

Stroke Rapid Assessment Unit, Island Health, Victoria, BC, Canada.

Nicole S Croteau (NS)

Department of Research and Capacity Building, Island Health, 1952 Bay Street, Victoria, BC, V8R1J8, Canada.
Department of Mathematics and Statistics, University of Victoria, Victoria, BC, Canada.

Kristine Votova (K)

Department of Research and Capacity Building, Island Health, 1952 Bay Street, Victoria, BC, V8R1J8, Canada. Kristine.Votova@viha.ca.
Division of Medical Sciences, University of Victoria, Victoria, BC, Canada. Kristine.Votova@viha.ca.

Colin Sedgwick (C)

Division of Medical Sciences, University of Victoria, Victoria, BC, Canada.

Robert F Balshaw (RF)

George & Fay Yee Centre for Healthcare Innovation, University of Manitoba, Winnipeg, MB, Canada.

Shelagh B Coutts (SB)

Departments of Clinical Neurosciences, Radiology, and Community Health Services, Hotchkiss Brain Institute, Foothills Medical Centre, University of Calgary, Calgary, AB, Canada.

Melanie Penn (M)

Stroke Rapid Assessment Unit, Island Health, Victoria, BC, Canada.

Kaitlin Blackwood (K)

Department of Research and Capacity Building, Island Health, 1952 Bay Street, Victoria, BC, V8R1J8, Canada.

Maximilian B Bibok (MB)

Department of Research and Capacity Building, Island Health, 1952 Bay Street, Victoria, BC, V8R1J8, Canada.

Viera Saly (V)

Stroke Rapid Assessment Unit, Island Health, Victoria, BC, Canada.

Janka Hegedus (J)

Stroke Rapid Assessment Unit, Island Health, Victoria, BC, Canada.
Departments of Clinical Neurosciences, Radiology, and Community Health Services, Hotchkiss Brain Institute, Foothills Medical Centre, University of Calgary, Calgary, AB, Canada.

Amy Y X Yu (AYX)

Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.

Charlotte Zerna (C)

Departments of Clinical Neurosciences, Radiology, and Community Health Services, Hotchkiss Brain Institute, Foothills Medical Centre, University of Calgary, Calgary, AB, Canada.

Evgenia Klourfeld (E)

Departments of Clinical Neurosciences, Radiology, and Community Health Services, Hotchkiss Brain Institute, Foothills Medical Centre, University of Calgary, Calgary, AB, Canada.

Mary L Lesperance (ML)

Department of Mathematics and Statistics, University of Victoria, Victoria, BC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH